Keyphrases
Monoclonal Antibody
100%
Hyperthermia
100%
Phase II Trial
100%
Iodine-131 (131I)
100%
Colorectal Adenocarcinoma
100%
Hyperemia
80%
Pharmacokinetics
40%
Thermometry
40%
Plasma Clearance
40%
Radioimmunotherapy
40%
Bi-exponential
40%
Tumor Response
20%
Malignancy
20%
Thrombocytopenia
20%
Tumor Site
20%
Low Dose Rate
20%
Dosimetry
20%
Liver Metastasis
20%
Specific Antibodies
20%
Whole-body
20%
Catheter
20%
Urinary Excretion
20%
Computed Tomography
20%
Tumor Volume
20%
Tmax
20%
Hematoma
20%
High-dose Radiation
20%
Partial Response
20%
Radiolabeled Antibody
20%
Colorectal Carcinoma
20%
Tmin
20%
Carcinoembryonic Antigen
20%
Carcinoembryonic Antigen Levels
20%
Metastatic Colorectal Adenocarcinoma
20%
Thermal Dose
20%
Dose Equivalent
20%
T Means
20%
Diagnostic Phase
20%
Body Clearance
20%
Medicine and Dentistry
Hyperthermia
100%
Iodine 131
100%
Colorectal Carcinoma
100%
Monoclonal Antibody
100%
Carcinoembryonic Antigen
100%
Hyperaemia
80%
Neoplasm
60%
Plasma Clearance
40%
Pharmacokinetics
40%
Diagnosis
40%
Radioimmunotherapy
40%
Liver Metastasis
20%
Computer Assisted Tomography
20%
Low Drug Dose
20%
Thrombocytopenia
20%
Hematoma
20%
Dosimetry
20%
Symptom
20%
Equivalent Dose
20%
Urinary Excretion
20%
Carcinoembryonic Antigen Monoclonal Antibody
20%
Cancer
20%
Antibodies
20%
Nursing and Health Professions
Colorectal Carcinoma
100%
Hyperthermia
100%
Iodine-131
100%
Monoclonal Antibody
100%
Carcinoembryonic Antigen
100%
Hyperaemia
80%
Diagnosis
40%
Plasma Clearance
40%
Neoplasm
40%
Radioimmunotherapy
40%
Tumor Volume
20%
Radiation Dose
20%
Symptom
20%
Catheter
20%
Low Drug Dose
20%
Computer Assisted Tomography
20%
Liver Metastasis
20%
Equivalent Dose
20%
Carcinoembryonic Antigen Monoclonal Antibody
20%
Dosimetry
20%
Thrombocytopenia
20%
Antibodies
20%
Hematoma
20%
Pharmacology, Toxicology and Pharmaceutical Science
Iodine-131
100%
Hyperthermia
100%
Colorectal Carcinoma
100%
Monoclonal Antibody
100%
Carcinoembryonic Antigen
100%
Hyperaemia
80%
Neoplasm
60%
Pharmacokinetics
40%
Dosimetry
20%
Symptom
20%
Liver Metastasis
20%
Carcinoembryonic Antigen Monoclonal Antibody
20%
Thrombocytopenia
20%
Antibodies
20%
Hematoma
20%